Cochlear Implant Comodal Treatment Evaluation
Research type
Research Study
Full title
Evaluation of a Comodal Treatment Approach in Cochlear Implant Recipients with a Contralateral Hearing Aid
IRAS ID
246895
Contact name
Dan Gnansia
Contact email
Sponsor organisation
Oticon Medical
Duration of Study in the UK
3 years, 0 months, 0 days
Research summary
The study aims to evaluate a new treatment approach named the co-modal treatment approach where a group of cochlear implant users will be fitted and programmed with a suitable hearing aid on the opposite ear simultaneously during their cochlear implant activation. The second treatment group, named the delayed bimodal group, will include cochlear implant users who will be fitted and programmed with a suitable hearing aid on the opposite ear sequentially following 3 months of their cochlear implant activation. The delayed bimodal treatment approach is most commonly practiced and in this study, the co-modal treatment approach will be evaluated against the delayed bimodal treatment approach.
REC name
London - Fulham Research Ethics Committee
REC reference
19/LO/0897
Date of REC Opinion
7 Jun 2019
REC opinion
Favourable Opinion